Development of Effective New Treatments for Multiple Myeloma
- 1 October 2005
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 23 (28) , 7207-7211
- https://doi.org/10.1200/jco.2005.02.4950
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Advances in biology of multiple myeloma: clinical applicationsBlood, 2004
- Approval Summary for Bortezomib for Injection in the Treatment of Multiple MyelomaClinical Cancer Research, 2004
- A Phase 2 Study of Bortezomib in Relapsed, Refractory MyelomaNew England Journal of Medicine, 2003
- Phase I Trial of the Proteasome Inhibitor PS-341 in Patients With Refractory Hematologic MalignanciesJournal of Clinical Oncology, 2002
- CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH‐DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATIONBritish Journal of Haematology, 1998